RT Journal Article SR Electronic T1 Atlas of functional connectivity relationships across rare and common genetic variants, traits, and psychiatric conditions JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2021.05.21.21257604 DO 10.1101/2021.05.21.21257604 A1 Clara A. Moreau A1 Kuldeep Kumar A1 Annabelle Harvey A1 Guillaume Huguet A1 Sebastian Urchs A1 Elise A. Douard A1 Laura M. Schultz A1 Hanad Sharmarke A1 Khadije Jizi A1 Charles-Olivier Martin A1 Nadine Younis A1 Petra Tamer A1 Thomas Rolland A1 Jean-Louis Martineau A1 Pierre Orban A1 David Shin A1 Ana Isabel Silva A1 Jeremy Hall A1 Marianne B.M. van den Bree A1 Michael J. Owen A1 David E. J. Linden A1 Aurelie Labbe A1 Anne M. Maillard A1 Tomasz J. Nowakowski A1 Sarah Lippé A1 Carrie E. Bearden A1 Laura Almasy A1 David C. Glahn A1 Paul M. Thompson A1 Thomas Bourgeron A1 Pierre Bellec A1 Sebastien Jacquemont YR 2021 UL http://medrxiv.org/content/early/2021/05/25/2021.05.21.21257604.abstract AB Polygenicity and pleiotropy are key properties of the genomic architecture of psychiatric disorders. An optimistic interpretation of polygenicity is that genomic variants converge on a limited set of mechanisms at some level from genes to behavior. Alternatively, convergence may be minimal or absent.We took advantage of brain connectivity, measured by resting-state functional MRI (rs- fMRI), as well as rare and common genomic variants to understand the effects of polygenicity and pleiotropy on large-scale brain networks, a distal step from genes to behavior. We processed ten rs-fMRI datasets including 32,988 individuals, to examine connectome-wide effects of 16 copy number variants (CNVs), 10 polygenic scores, 6 cognitive and brain morphometry traits, and 4 idiopathic psychiatric conditions.Although effect sizes of CNVs on connectivity were correlated to cognition and number of genes, increasing polygenicity was associated with decreasing effect sizes on connectivity. Accordingly, the effect sizes of polygenic scores on connectivity were 6-fold lower compared to CNVs. Despite this heterogeneity of connectivity profiles, multivariate analysis identified convergence of genetic risks and psychiatric disorders on the thalamus and the somatomotor network. Based on spatial correlations with transcriptomic data, we hypothesize that excitatory thalamic neurons may be primary contributors to brain alteration profiles shared across genetic risks and conditions. Finally, pleiotropy measured by genetic and transcriptomic correlations between 38 pairs of conditions/traits showed significant concordance with connectomic correlations, suggesting a substantial causal genetic component for shared connectivity.Such findings open avenues to delineate general mechanisms - amenable to intervention - across conditions and genetic risks.One sentence summary Effects of rare and common genomic variants on brain functional connectivity shed light on the impact of polygenicity and pleiotropy in psychiatry.Competing Interest StatementP.M.T. received partial research grant support from Biogen, Inc., for research unrelated to this study. Other authors did not have a conflict of interest.Funding StatementThis research was supported by Compute Canada (ID 3037 and gsf-624), the Brain Canada Multi investigator research initiative (MIRI), Canada First Research Excellence Fund, Institute of Data Valorization, Healthy Brain Healthy Lives (Dr. Jacquemont). Dr. Jacquemont is a recipient of a Canada Research Chair in neurodevelopmental disorders, and a chair from the Jeanne et Jean Louis Levesque Foundation. This work was supported by a grant from the Brain Canada Multi-Investigator initiative (Dr. Jacquemont) and a grant from The Canadian Institutes of Health Research (CIHR 400528, Dr. Jacquemont). The Cardiff CNV cohort was supported by the Wellcome Trust Strategic Award DEFINE and the National Centre for Mental Health with funds from Health and Care Research Wales (code 100202/Z/12/Z). The CHUV cohort was supported by the SNF (Maillard Anne, Project, PMPDP3 171331). Data from the UCLA cohort provided by Dr. Bearden (participants with 22q11.2 deletions or duplications and controls) was supported through grants from the NIH (U54EB020403), NIMH (R01MH085953, R01MH100900, 1U01MH119736, R21MH116473), and the Simons Foundation (SFARI Explorer Award). Finally, data from another study were obtained through the OpenFMRI project (http://openfmri.org) from the Consortium for Neuropsychiatric Phenomics (CNP), which was supported by NIH Roadmap for Medical Research grants UL1-DE019580, RL1MH083268, RL1MH083269, RL1DA024853, RL1MH083270, RL1LM009833, PL1MH083271, and PL1NS062410. Dr P. Bellec is a fellow (Chercheur boursier Junior 2) of the Fonds de recherche du Quebec - Sante, Data preprocessing and analyses were supported in part by the Courtois foundation (Dr Bellec). This work was supported by Simons Foundation Grant Nos. SFARI219193 and SFARI274424. We thank all of the families at the participating Simons Variation in Individuals Project (VIP) sites, as well as the Simons VIP Consortium. We appreciate obtaining access to imaging and phenotypic data on SFARI Base. Approved researchers can obtain the Simons VIP population dataset described in this study by applying at https://base.sfari.org. We are grateful to all families who participated in the 16p11.2 European Consortium. Dr. P. Thompson was funded in part by the U.S. NIH grants R01MH116147, P41EB015922, R01MH111671, and U01 AG068057. Ms. Petra Tamer received the Canadian Institute of Health Research (CIHR) Scholarship.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB approved by the research center of Sainte Justine hospital MP-21-2016-946, 4165.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData from UK Biobank was downloaded under the application 40980, and can be accessed via their standard data access procedure (see http://www.ukbiobank.ac.uk/register-apply). UK Biobank CNVs were called using the pipeline developed in Jacquemont Lab, and described in https://github.com/labjacquemont/MIND-GENESPARALLELCNV. The final CNV calls are available from UK Biobank returned datasets (Return ID: 3104, https://biobank.ndph.ox.ac.uk/ukb/dset.cgi?id=3104). ABIDE1, COBRE, ADHD200, CNP, 16p11.2 SVIP data are publicly available: http://fcon_1000.projects.nitrc.org/indi/abide/abide_I.html, http://schizconnect.org/queries/new, http://fcon_1000.projects.nitrc.org/indi/adhd200/, https://www.openfmri.org/dataset/ds000030/, https://www.sfari.org/funded-project/simons-variation-in-individuals-project-simons-vip/. The 22q11.2 UCLA raw data are currently available by request from the PI. Raw imaging data for the Montreal rare genomic disorder family dataset is going to be available on the LORIS platform in 2022. The Cardiff raw data is not publicly available yet, contact the PI for further information. Allen Human Brain Atlas is available from https://human.brain-map.org/. Single-cell expression data is available from the National Center for Biotechnology Information under the accession code GSE97942 (https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE97942). All processed connectomes are available through a request to the corresponding authors. Code for all analyses and visualizations, beta values, and p-values for the 36 FC-profiles are available online through the GitHub platform with Jupyter notebook: https://github.com/claramoreau9/NeuropsychiatricCNVs_Connectivityhttps://github.com/claramoreau9/NeuropsychiatricCNVs_Connectivity